focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.90
Bid: 3.30
Ask: 4.50
Change: -0.10 (-2.50%)
Spread: 1.20 (36.364%)
Open: 4.00
High: 0.00
Low: 0.00
Prev. Close: 4.00
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: G4S And Tullow Oil Lead FTSE 100 Gainers

Wed, 12th Nov 2014 12:02

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Wednesday.
-------
FTSE 100 WINNERS
-------
G4S, up 4.3%. The security company said organic revenue rose 4.2% in the first nine months of the year and it has agreed new contracts with annual revenues of over GBP870 million and total contract value of GBP1.7 billion. Contract retention for the nine months was similar to historical levels, at slightly above 90%, the company said.

Tullow Oil, up 1.5%. The oil explorer said it is reviewing its capital expenditure and costs, with overall exploration spending significantly reduced and focused primarily on East Africa where it has major basin-opening potential.
-------
FTSE 100 LOSERS
-------
Sainsbury's, down 5.4%. The supermarket operator swung to a pretax loss in the first half of the year, and outlined plans to cuts costs and capital expenditure. Pretax loss was GBP290 million for the 28 weeks to September 27 from a profit of GBP433 million in the same period a year earlier. First-half revenue fell 0.1% to GBP12.67 billion. It maintained its interim dividend, but its full-year dividend is expected to be cut.

Capita, down 5%. The outsourcing company said it has secured GBP1.63 billion of major sales so far this year, down from GBP2.9 billion in the same period last year when it had booked its largest ever contract worth GBP1.2 billion with O2.

SSE, down 2.7%. The utility reported a drop in pretax profit in the first half of the year due to warmer weather, lower electricity output and weak gas prices. For the six months ended September 30, pretax profit fell 6.2% to GBP316.6 million compared with GBP337.4 million a year earlier, mainly driven by a GBP22.1 million loss from its share of joint ventures.

Barclays, down 2%. The bank was among the five investigated by regulators over its FX dealings but remains in talks with regulators over its settlement. It has set aside GBP500 million in provisions to cover potential fines.

Burberry, down 1.2%. The luxury fashion retailer reported a 14% rise in underlying revenue of GBP1.1 billion but said it expects some pressure on full-year margin, a reflection of the strong pound, a more difficult external environment, and continued investments.

Royal Bank of Scotland, down 0.4%. The bank was one of five fined a total USD3.38 billion by UK, US and Swiss regulators for failings in its FX dealing operations. RBS was fined GBP399 million but said this is fully covered by provisions made in the third quarter.
-------
FTSE 250 WINNERS
-------
Essentra, up 2.5%. The company said it will buy the specialist packing arm of Clondalkin Group in a USD455 million deal, issuing shares to cover GBP160 million of the consideration. Clondalkin, which provides secondary packaging products for the pharmaceutical and healthcare industries, is owned by an affiliate of US private equity house Warburg Pincus and Essentra expects to complete the deal in the first quarter of 2015.

Moneysupermarket.com, up 2%. The price comparison website said it remains confident of meeting its expectations for the full year, after the "positive momentum and solid margins" seen in the third quarter continued through October. Third-quarter revenue rose by 18% year-on-year to GBP66.8 million, driven by increases in MoneySuperMarket.com, MoneySavingExpert.com, and TravelSupermarket.com, the company said
-------
FTSE 250 LOSERS
-------
SIG, down 7.5%. The building products distributor lowered its expectations for the year due to weak economic conditions in Europe, although it also raised its cost-benefit targets from the strategic initiatives it is taking.

Playtech, down 7.5%. Credit Suisse cut its rating on the stock to Underperform from Neutral and lowered its price target to 580 pence from 780p.

Diploma, down 1.6%. The company said Chairman John Rennocks is to step down from his role after the company's annual general meeting in January, appointing John Nicholas, currently a senior independent director on Diploma's board.
-------
AIM ALL-SHARE WINNERS
-------
Mountfield, up 8.1%. The company said its Connaught Access Flooring subsidiary has won a contract worth around GBP4.5 million to supply and install access flooring at a newly-built office development in the City of London. Work will start in January 2015 and is expected to be completed in the first quarter of 2016.

Solo Oil, up 7%. The company said it is awaiting formal approval from Tanzanian authorities for a deal that will see Solo buy a stake in the Kiliwani North Development license from Aminex, and the companies expect the deal to close shortly.
-------
AIM ALL-SHARE LOSERS
-------
Proteome Sciences, down 16%. The company said contract delays will mean its full-year revenue will come in below market expectations and lower than the revenue posted last year.

Quindell, down 9.6%. The company is understood to be on the brink of a formal probe by the City regulator over a share-transaction controversy which has caused its share price to plunge in the past week, the Daily Mail reported. The FCA declined to comment to Alliance News.

Physiomics, down 4%. The company posted a slightly narrowed loss in its year to end-June of GBP464,252, down from GBP543,791 a year before, as revenue rose to GBP267,903 from GBP240,000.
-------
By Ian Edmondson; ianedmondson@alliancenews.com;

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
16 May 2024 12:23

IN BRIEF: Proteome Sciences promises AGM return to growth in 2024

Proteome Sciences PLC - London-based protein-focused drug development services provider - Proteome tells annual general meeting on Thursday it is "confident and well positioned to see the business return to growth in 2024". The company swung to a loss in 2023, as revenue fell by 36% due to a delay in the timing of services contracts. Since the start of 2024, Proteome has seen "significant" customer engagement and interest in proteomics services, including a GBP500,000 contract for an unnamed US biopharmaceutical company to use Proteome's mass spectrometry services, announced late last month.

Read more
16 May 2024 10:41

AIM WINNERS & LOSERS: Proteome Sciences eyes return to growth in 2024

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
26 Apr 2024 11:18

Proteome wins GBP500,000 deal to supply mass spectrometry services

(Alliance News) - Proteome Sciences PLC on Friday said it won a contract from an unnamed US biopharmaceutical company to use Proteome's mass spectrometry services.

Read more
26 Apr 2024 10:40

AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
26 Apr 2024 09:45

Proteome Sciences secures contract win with US biopharmaceutical firm

(Sharecast News) - Contract proteomics service Proteome Sciences has secured a contract win from a US biopharmaceutical company using the company's mass spectrometry services for the analysis of samples for an on-going clinical trial.

Read more
26 Apr 2024 09:14

LONDON MARKET OPEN: Thoma Bravo snaps up Darktrace for USD5 billion

(Alliance News) - Stock prices in London opened higher on Friday, as investors shook off nerves ahead of US inflation data this afternoon.

Read more
10 Apr 2024 11:26

Proteome Sciences shares drop as revenue plunges and swings to loss

(Alliance News) - Proteome Sciences PLC on Wednesday said it swung to a loss in 2023 on higher costs, and saw its revenue plunge on contract delays.

Read more
2 Jan 2024 14:44

Proteome launches San Diego lab operations

(Sharecast News) - Proteomics services provider Proteome Sciences announced the installation and start of operations at its new laboratory in San Diego, California, on Tuesday.

Read more
2 Jan 2024 10:52

IN BRIEF: Proteome Sciences says San Diego lab now fully operational

Proteome Sciences PLC - London-based protein-focused drug development services provider - Completes installation and setup of equipment in its new lab in San Diego, California. The lab is now fully operational. Back in May, Proteome had announced it was expanding its proteomics services to the US. Says that the lab is "well placed to serve demand from a growing number of US customers looking to outsource proteomics projects to underpin their drug development programmes".

Read more
1 Dec 2023 12:01

Proteome Sciences issues profit warning after project delays

(Sharecast News) - Proteome Sciences, the AIM-listed protein sequencing contract research organisation, has warned it will swing to a net loss this year with full-year sales lower than expected.

Read more
30 Nov 2023 11:04

AIM WINNERS & LOSERS: Totally slides again; Proteome warns on earnings

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
30 Nov 2023 09:42

Proteome Sciences shares drop as cuts annual revenue outlook

(Alliance News) - Proteome Sciences PLC shares plummeted on Thursday, after it cut its revenue outlook for 2023 amid delays to projects.

Read more
2 Oct 2023 10:17

Proteome Sciences sees shares surge on SysQuant service launch

(Alliance News) - Proteome Sciences PLC on Monday launched SysQuant SCP, a commercial service for single cell proteomics using isobaric labelling reagents.

Read more
25 Aug 2023 12:07

LONDON MARKET MIDDAY: FTSE 100 pushes higher ahead of Fed chair speech

(Alliance News) - The FTSE 100 edged higher at midday on Friday as all eyes turned to US Federal Reserve Chair Jerome Powell's address at Jackson Hole later in the day.

Read more
25 Aug 2023 10:26

AIM WINNERS & LOSERS: Panthera Resources secures litigation financing

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.